ALPHATEC HOLDINGS, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
ALPHATEC HOLDINGS, INC. (ATEC) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $2.65 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-04
- ALPHATEC HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $1.32M, a 10.97% increase year-over-year.
- ALPHATEC HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $1.32M, a 3.93% increase year-over-year.
- ALPHATEC HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $1.38M, a 1.35% decline year-over-year.
- ALPHATEC HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $1.22M, a 4.08% decline year-over-year.
- ALPHATEC HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $5.07M, a 3.45% increase from fiscal 2024.
- ALPHATEC HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $4.90M, a 38.36% increase from fiscal 2023.
- ALPHATEC HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $3.54M, a 28.37% increase from fiscal 2022.
- ALPHATEC HOLDINGS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $2.76M, a 19.25% decline from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.65M 10-Q · filed 2026-08-04 | $4.03M derived: sum of 3 quarters · filed 2026-08-04 | $5.25M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $1.32M 10-Q · filed 2026-05-05 | $2.71M derived: sum of 2 quarters · filed 2026-05-05 | $3.93M derived: sum of 3 quarters · filed 2026-05-05 | $5.12M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.61M derived: sum of 2 quarters · filed 2026-02-24 | $3.80M derived: sum of 3 quarters · filed 2026-08-04 | $5.07M 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.42M derived: sum of 2 quarters · filed 2026-08-04 | $3.69M 10-Q · filed 2025-10-30 | $5.09M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.46M 10-Q · filed 2026-08-04 | $3.87M derived: sum of 3 quarters · filed 2026-08-04 | $5.14M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $1.27M 10-Q · filed 2026-05-05 | $2.67M derived: sum of 2 quarters · filed 2026-05-05 | $3.95M derived: sum of 3 quarters · filed 2026-05-05 | $5.14M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.68M derived: sum of 2 quarters · filed 2026-02-24 | $3.87M derived: sum of 3 quarters · filed 2026-02-24 | $4.90M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.47M derived: sum of 2 quarters · filed 2025-10-30 | $3.50M 10-Q · filed 2025-10-30 | $4.44M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $2.23M 10-Q · filed 2025-07-31 | $3.17M derived: sum of 3 quarters · filed 2026-02-24 | $4.08M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $1.03M 10-Q · filed 2025-05-01 | $1.98M derived: sum of 2 quarters · filed 2026-02-24 | $2.88M derived: sum of 3 quarters · filed 2026-02-24 | $3.74M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $945.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.85M derived: sum of 2 quarters · filed 2026-02-24 | $2.71M derived: sum of 3 quarters · filed 2026-02-24 | $3.54M 10-K · filed 2026-02-24 |
| 2023-09-30 | $909.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $1.77M derived: sum of 2 quarters · filed 2024-10-30 | $2.60M 10-Q · filed 2024-10-30 | $3.43M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $858.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $1.69M 10-Q · filed 2024-07-31 | $2.52M derived: sum of 3 quarters · filed 2025-02-26 | $3.32M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $831.00K 10-Q · filed 2024-05-07 | $1.66M derived: sum of 2 quarters · filed 2025-02-26 | $2.46M derived: sum of 3 quarters · filed 2025-02-26 | $3.03M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $833.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.63M derived: sum of 2 quarters · filed 2025-02-26 | $2.20M derived: sum of 3 quarters · filed 2025-02-26 | $2.76M 10-K · filed 2025-02-26 |
| 2022-09-30 | $799.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $1.36M derived: sum of 2 quarters · filed 2023-11-06 | $1.93M 10-Q · filed 2023-11-06 | $2.62M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $565.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.13M 10-Q · filed 2023-08-03 | $1.82M derived: sum of 3 quarters · filed 2024-02-27 | $2.60M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $563.00K 10-Q · filed 2023-05-04 | $1.25M derived: sum of 2 quarters · filed 2024-02-27 | $2.03M derived: sum of 3 quarters · filed 2024-02-27 | $2.96M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $688.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.47M derived: sum of 2 quarters · filed 2024-02-27 | $2.40M derived: sum of 3 quarters · filed 2024-02-27 | $3.42M 10-K · filed 2024-02-27 |
| 2021-09-30 | $780.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.71M derived: sum of 2 quarters · filed 2022-11-03 | $2.73M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $928.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.95M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $1.02M 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $683.00K 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |